| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,824 |
1,763 |
$194K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
720 |
690 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
246 |
246 |
$35K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
71 |
71 |
$8K |
| 99385 |
|
57 |
57 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
51 |
51 |
$5K |
| 90750 |
|
25 |
25 |
$5K |
| 99386 |
|
37 |
37 |
$5K |
| 96127 |
|
780 |
611 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
66 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
137 |
128 |
$3K |
| 90674 |
|
76 |
76 |
$2K |
| 99421 |
|
146 |
145 |
$2K |
| 99422 |
|
59 |
59 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
205 |
205 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$513.48 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
14 |
$346.68 |